AUS
NZ
UK
CA
USA
IND
Highlights
Nexus Minerals confirms extensive gold mineralisation at Wallbrook Gold Project
Solis Minerals intersects visible copper and gold at its Chancho al Palo Project in Peru
Percheron Therapeutics releases preclinical data showing enhanced efficacy of radiotherapy
The ASX Small Ordinaries Index advanced as small cap mining and biotechnology companies released exploration and clinical updates, setting a constructive tone ahead of the Noosa Mining Investor Conference. The movement reflects renewed interest in resource projects and therapeutic innovation across Australia and international markets.
The performance of key players such as Nexus Minerals Ltd (ASX:NXM), Solis Minerals Ltd (ASX:SLM), and Percheron Therapeutics Ltd (ASX:PER) marked a session of upbeat sentiment, supported by operational progress and expanded exploration outcomes.
Nexus Minerals Unveils Large-Scale Gold System at Payns Prospect
Nexus Minerals Ltd has confirmed widespread gold mineralisation at its Payns Prospect, part of the Wallbrook Gold Project located in Western Australia. The reverse circulation program has outlined a broad mineralised footprint, further validating the company’s previous aircore drilling results.
Drilling activity covered a significant area, with multiple holes intersecting gold grades across varying depths. The geological model now supports a large-scale gold system, positioning the Payns Prospect as a core focus for the company’s future exploration activities.
Solis Minerals Delivers More Visible Copper and Gold from Peru Project
Solis Minerals Ltd reported continued success from its Chancho al Palo Project in Peru, where the company recently completed a second diamond drill hole. The new hole confirmed visible copper and gold mineralisation and extended mineralised zones, reinforcing prior findings.
The project, fully owned by Solis, forms part of its broader strategy to unlock value from underexplored polymetallic systems in South America. Ongoing work includes geological modelling and planning for further drilling phases based on visual confirmation of mineral-bearing structures.
Percheron Therapeutics Shares Promising Results in Cancer Research
Percheron Therapeutics Ltd released new preclinical data from a Stanford University-led study assessing its antibody candidate HMBD-002. The study demonstrated that HMBD-002, when combined with radiotherapy, improved survival outcomes in squamous cell carcinoma of the head and neck.
The data highlights the therapeutic effects of targeting VISTA, a key immune checkpoint protein. This early-stage validation supports the continued development of HMBD-002 for solid tumours, with future studies expected to expand into clinical testing pathways.
Dynamic Metals and Race Oncology Also Report Strategic Developments
Dynamic Metals Ltd (ASX:DYM) disclosed encouraging results from its drilling campaign at Cognac West, part of the Widgiemooltha Project. The findings confirmed copper and gold zones with notable intercepts, extending the known mineralised area at the site.
Race Oncology Ltd (ASX:RAC) shared its latest quarterly update, reporting key achievements within its RC220 program. The company confirmed safe treatment of the first patient in a combination therapy setting and maintained strong research and development activity throughout the period.
Technology and Health Trends Drive IPO Momentum and Sector Innovation
Alongside exploration progress, the broader small cap ecosystem showed signs of recovery in the initial public offering space. Technology companies such as Heartflow and Carlsmed are moving ahead with IPO plans, highlighting renewed confidence in digital health and surgical innovation.
Meanwhile, cybersecurity concerns remain in focus for healthcare firms. A recent report by Fortified Health Security warned of continuing vulnerabilities, despite advances in defence mechanisms. These developments underscore the importance of robust data protection protocols within the biotech and medtech sectors.
Financial Updates and Corporate Activity Round Out the Session
Insignia Financial Ltd (ASX:IFL) revealed a binding Scheme Implementation Deed with CC Capital Partners. The agreement reflects the latest in a series of M&A developments among ASX-listed entities.
88 Energy Ltd (ASX:88E) provided an update on its Alaskan operations, with new lease awards and revised seismic data expanding its resource base. These announcements contributed to a dynamic close for the small cap segment ahead of a key industry conference.
